Glaucoma, age-related macular degeneration, and other major causes of permanent vision loss are associated with the buildup of fluid, metabolic waste, and inflammatory substances at the back of the eye. Until now, researchers have struggled to explain exactly how this sensitive region removes unwanted materials.

A research team from the University of British Columbia (UBC) and the University of Toronto has identified a previously unrecognized drainage route called the posterior ocular lymphatic outflow (POLO) pathway. The system is thought to transport fluid and waste products from behind the eye to the lymphatic network, helping maintain fluid balance, remove waste, and support immune defenses.

The discovery, demonstrated in mice, gives scientists a new way to study how the eye protects its delicate tissues and what may happen when waste removal is impaired.

“The retina is one of the most metabolically active parts of the body, constantly producing byproducts that need to be removed,” said Dr. Neil Gupta, professor and chair of UBC’s Department of Ophthalmology and Visual Sciences. “This discovery helps explain how the eye flushes out this waste and promises to change the way we think about and treat a variety of eye conditions.”

Hidden eye drainage system may reveal new treatment targets

The retina is the light-sensitive tissue at the back of the eye. It requires considerable energy to convert incoming light into signals that the brain can interpret. This constant activity produces metabolic byproducts that must be removed for surrounding tissues to function properly.

A buildup of fluid and waste can damage the eye. Glaucoma, macular degeneration, and other retinal diseases are associated with changes in fluid regulation, cellular waste accumulation, tissue stress, and inflammation.

Age-related macular degeneration alone affects approximately 2.5 million Canadians, highlighting the potential importance of understanding the processes that help keep the retina healthy.

The newly identified POLO pathway suggests that the back of the eye has a natural mechanism for moving unwanted substances out of this vulnerable region. If scientists can determine how the pathway works and whether it can be strengthened, it could become a target for treatments designed to protect vision.

“This provides a completely new framework for understanding these diseases and potential targets for treatment,” Dr. Gupta said. “The question now is how can we enhance or leverage this purification system to treat or prevent disease?”

Discovery challenges more than a century of assumptions

For more than 100 years, scientists generally believed that the eye lacked the lymphatic drainage system found in nearly every other organ.

The lymphatic system consists of vessels and tissues that collect excess body fluid, transport certain waste products, and help regulate the immune response. It works alongside the blood circulation system to maintain the health of the body.

The idea that the eye was largely disconnected from this network began to change in 2009, when Dr. Gupta and Dr. Yeni Yucel identified lymph-related drainage pathways in the front of the eye.

They named this system the uveal lymphatic pathway and provided evidence that the eye had a previously unrecognized connection to the body’s fluid-removal mechanisms.

Dr. Yucel, professor and director of ophthalmic pathology at the University of Toronto, continued investigating whether similar pathways existed elsewhere in the eye.

Despite the earlier discovery, the back of the eye remained relatively unexplored. This was an important gap because the retina and surrounding tissues are affected by some of the most serious diseases that cause permanent vision loss.

“The retina is responsible for vision, and many of the most serious vision-loss diseases occur here,” Dr. Yucel said. “It’s important to understand how this part of the eye maintains a balanced environment and flow of substances.”

Researchers track a secret drainage route behind the retina

To investigate how fluid leaves the back of the eye, the researchers combined several advanced imaging methods in mice, including magnetic resonance imaging (MRI), near-infrared fluorescence imaging, and microscopy.

They placed fluorescent tracer molecules in a narrow space at the back of the eye. Because the molecules can be detected as they move, the researchers were able to track the fluid’s route and determine where it traveled.

The team found small lymphatic vessels in the choroid, a thin, blood-vessel-rich layer beneath the retina. The choroid helps nourish the outer retina, but lymphatic vessels had not previously been established in this area.

The researchers observed fluid moving from the back of the eye into the surrounding orbital tissue, which occupies the space around the eyeball. Within minutes, the tracer reached nearby lymph nodes, linking the newly identified eye drainage pathway to the body’s wider lymphatic system.

The findings provide evidence that fluid from the back of the eye can enter active drainage pathways rather than remaining trapped within the eye.

“Lymphatic vessels were not thought to exist in the choroid, so the research team used multiple techniques to demonstrate the presence and function of lymphatic vessels,” added Dr. Yucel, a pathologist and scientist at St. Michael’s Hospital. “We were surprised to see a direct route for fluid to exit the eye and connect to the lymphatic system. This suggests an active clearance pathway deep within the eye, which may play an important role in removing fluid, proteins, and inflammatory substances that accumulate in disease.”

Could the eye’s lymphatic pathway help prevent blindness?

The discovery offers a new explanation for how fluid and waste products may drain from the back of the eye, but important questions remain.

Because the experiments were conducted in mice, further research is needed to establish how the POLO pathway functions in humans. Researchers must also determine whether changes in this drainage system contribute to eye disease and whether its activity can be safely modified.

If these questions are answered, the pathway could eventually offer new possibilities for treatment.

One potential approach could involve treatments that improve fluid clearance and reduce the accumulation of substances associated with inflammation and tissue damage. Another possibility is using knowledge of this drainage route to improve drug delivery to structures at the back of the eye.

Understanding the system could also help researchers investigate how pressure, inflammation, and fluid movement interact in conditions such as glaucoma and age-related macular degeneration.

These possibilities are not established treatments and remain open areas for future research. Nevertheless, the discovery provides scientists with new anatomical pathways to study and may help explain a process that has remained poorly understood for decades.

“This is a fundamental discovery that shows the eye is not as closed a system as previously thought,” Dr. Gupta said. “It gives us new maps, new mechanics, and a new set of questions to explore.”

The research results were published in the scientific journal Translational Vision Science & Technology.

This research was supported by the Canadian Institutes of Health Research, the Canadian Glaucoma Research Association, the Henry Farrugia Eye Research Fund, the Canadian Space Agency, the Dorothy Pitts Chair, the Stephen M. Dorrance Chair, the Thor and Nicki Eaton Research Fund, and the Canadian Innovation Leaders Opportunity Fund.